Disclosures for "Non-Invasive Magnetic Resonance Imaging Monitoring of Glycogen Accumulation in a Mouse Model of Pompe Disease"
-
Dr. Zeng has nothing to disclose.
-
Dr. Timm has received personal compensation for serving as an employee of Amicus Therapeutics.
-
Dr. Johnson has received personal compensation for serving as an employee of Amicus Therapeutics. Dr. Johnson has stock in Amicus Therapeutics.
-
Dr. Mehta has received personal compensation for serving as an employee of Amicus Therapeutics. Dr. Mehta has stock in Amicus Therapeutics.
-
Dr. Fox has received personal compensation for serving as an employee of Amicus Therapeutics. Dr. Fox has stock in Amicus Therapeutics.
-
Dr. LI has nothing to disclose.
-
Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus therapeutics. Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Yadav has received research support from Amicus therapeutics. Dr. Yadav has received intellectual property interests from a discovery or technology relating to health care.